← Leaderboards
Paul H Johnson
Epigenx Pharmaceuticals
$1,023,432
Attributed
$1,023,432
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,023,432 · 3
By mechanism
R44$720,264 · 1
R43$303,168 · 2
Top collaborators
No co-investigators on record.
Most similar at Epigenx Pharmaceuticals
Same institution · by research overlap
- Judy Anne Mikovits$1,744,687
Others in their field
Top investigators on “Dna Methylation”
- Richard K. Wilson · Washington University$74,307,196
- Bing Ren · Ludwig Institute For Cancer Research$63,053,519
- Leonardo Trasande · New York University School Of Medicine$50,897,521
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$47,754,231
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$46,590,951
- Joseph R Ecker · University Of California, San Diego$45,558,745
Research focus
Dna MethylationHigh Throughput TechnologyPolymerase Chain ReactionTechnology /Technique DevelopmentCpg IslandsDrug Design /Synthesis /ProductionDrug Screening /EvaluationEnzyme InhibitorsGenomeBacterial ProteinsChemical Registry /ResourceChemical Structure FunctionChromosome AberrationsAntibioticsMatrix Assisted Laser Desorption IonizationMethylguanine Dna MethyltransferaseMethyltransferaseCell LineRestriction EndonucleasesBreast NeoplasmsMicroarray TechnologyNeoplasm /Cancer DiagnosisNeoplasm /Cancer GeneticsNeoplastic Cell
Grant awards (5)
Development of DAM Inhibitors as Novel Antibiotics$344,474
R44 · FY2004 · AI
Development of DAM Inhibitors as Novel Antibiotics$375,790
R44 · FY2003 · AI
Whole Genome Methylation Assay$103,000
R43 · FY2002 · CA
Technology for Genome-Wide Cancer Methylation Profiling$100,168
R43 · FY2002 · CA
Whole Genome Methylation Assay$100,000
R43 · FY2001 · CA